Julien Emmanuelle, El Omar Reine, Tavian Manuela
Inserm UMR-S949, Etablissement Français du Sang-ALCA, University of Strasbourg, France.
FEBS Lett. 2016 Nov;590(22):3987-4001. doi: 10.1002/1873-3468.12389. Epub 2016 Sep 22.
The continuous generation of blood cells throughout life relies on the existence of hematopoietic stem cells (HSC) generated during embryogenesis. Given the importance of HSC transplantation in cell-based therapeutic approaches, considerable efforts have been made toward understanding the developmental origins of embryonic HSC. Adult-type HSC are first generated in the aorta-gonad-mesonephros (AGM) region between days 27 and 40 of human embryonic development, but an elusive blood-forming potential is present earlier in the underlying splanchnopleura. It is relatively well accepted that the HSC emerge in the AGM through a hemogenic endothelium, but the direct precursor of this cell type remains to be clearly identified. This review is intended to summarize the recent advances made to understand the origins of hematopoietic stem cells in the early human embryo. In addition, we discuss in detail the discovery of the angiotensin-converting enzyme (ACE) as a novel marker of human HSC and of prehematopoietic precursors inside the embryo.
终身持续产生血细胞依赖于胚胎发生过程中产生的造血干细胞(HSC)的存在。鉴于HSC移植在基于细胞的治疗方法中的重要性,人们在了解胚胎HSC的发育起源方面付出了巨大努力。成人型HSC首先在人类胚胎发育第27至40天之间的主动脉-性腺-中肾(AGM)区域产生,但在其下方的脏壁中胚层中更早存在难以捉摸的造血潜能。相对而言,人们普遍认为HSC通过造血内皮在AGM中出现,但这种细胞类型的直接前体仍有待明确鉴定。这篇综述旨在总结在了解人类早期胚胎中造血干细胞起源方面取得的最新进展。此外,我们详细讨论了血管紧张素转换酶(ACE)作为人类HSC和胚胎内造血前体细胞的新型标志物的发现。